Open App →
Back to News Feed
PR Newswire October 6, 2026 positive

Epicore Biosystems and MECFA Announce Collaboration to Expand Access to Wearable Sweat Chloride Testing for Cystic Fibrosis

AI / LLM
<p>The collaboration aims to expand access to cystic fibrosis sweat chloride monitoring in the Middle East and other underserved regions. CAMBRIDGE, Mass., Oct. 6, 2026 /PRNewswire/ -- Epicore Biosystems, a leader in wearable biosensor platforms for continuous, non-invasive health...</p>
Read original article ↗

Related Articles

InventHelp Inventor Develops Improved Headphones to Increase Awareness (DCD-426)

PITTSBURGH, Oct. 6, 2026 /PRNewswire/ -- "I thought there should be a way to see behind you when using headphones to inc

PR Newswire · October 6, 2026

Avarra Raises $17 Million on a Contrarian Bet: AI that rapidly upskills GTM teams rather than simply automating routine work

The round is led by Duration Ventures, with participation from Lightspeed Venture Partners, Draper Associates, the GTMfu

PR Newswire · October 6, 2026

Army Expands Striveworks' AI Role to Europe Following Successful U.S. Deployments

Chariot Forge software will support missions to identify, analyze and confirm military intelligence with human review bu

PR Newswire · October 6, 2026